Partial match stem cell transplants show strong survival rates

Partial match parity: Increasing the donor pool for hematopoietic stem cell transplantation

Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors when they are treated with the immune-suppressing drug cyclophosphamide. Survival rates at one year were on par with rates seen in other studies with fully matched donors.

Stem cell donor drive set for Saturday in Little Rock | Northwest Arkansas Democrat-Gazette

The world's largest blood stem cell donor center is looking for potential matches for people in need of a transplant.

Partial match stem cell transplants show strong survival rates

Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options.

Prognostic factors of survival in second allogeneic hematopoietic transplantation

Allogeneic stem cell transplantation (alloSCT) remains a potentially curative treatment for patients with hematologic malignancies. Nevertheless, relapse a

Circulating Hematopoietic Stem Cells Show Diagnostic Potential

Researchers have tracked how circulating stem cells that support the lifelong production of blood and immune cells change across a person’s lifespan, which could simplify the diagnosis of blood cancers. The findings, in Nature Medicine, provide reference ranges for these hematopoietic stem and progenitor cells (HSPCs) and could facilitate the clinical application of single-cell genomics in hematology. In particular, the study suggests that analy…